GUTSAGA / PharmaBookDoes buying cheaper always mean earning more?
100%
Book page 55
Book page 56
Book page 57
Book page 58
Book page 59
Book page 60
Book page 61
Book page 62
Book page 63
Book page 64
Book page 65
Book page 66

Does buying cheaper always mean earning more?

PART II · STAGE 5

Does buying cheaper always mean earning more?

Direct purchasing, private label, and parallel trade

An in-house warehouse has already changed the chain's position. Demand is aggregated, volumes are visible in one place, and the chain can distribute the product onward itself.

If we are already large enough, why buy only from a distributor?

The manufacturer may offer a lower price. But that often comes with a larger lot, a longer replenishment lead time, less flexibility, more days of inventory, and more capital tied up in product.

Buying cheaper is not the same as earning more.

A lower price is only one line of the economics

PURCHASE PRICE

LOT becomes larger

INVENTORY may increase

CAPITAL stays tied up longer

RISK shifts to the chain

A DISCOUNT IS NOT THE SAME AS AN ECONOMIC OUTCOME

Buying cheaper makes sense only when the entire function delivers a better economic outcome for the company.

Book page 56

DIRECT CONTRACT

When does a manufacturer begin to see a pharmacy chain as a direct customer?

A single pharmacy is rarely of interest to a manufacturer as a major buyer. Even a chain may still look like many small locations if each orders separately and requires separate delivery.

HOW RETAIL DEMAND BECOMES A DIRECT CONTRACT

MANY LOCAL LOCATIONS

AGGREGATED DEMAND · ONE ORDER · ONE RECEIPT

THE MANUFACTURER SEES ONE CUSTOMER

PHARMACY APHARMACY BPHARMACY CPHARMACY DPHARMACY E

DEMAND — from all pharmacies

ONE RECEIPT — at one location

VOLUME — by product

TO PHARMACIES — using the chain's own resources

CONTRACT — larger

Aggregation turns retail demand into purchasing power.

But a direct contract is attractive only when the chain can take over part of the distributor's function in an economically justified way.

TWO SOURCES OF SUPPLY

If the manufacturer offers a lower price than the distributor, does that mean a direct contract is more advantageous?

Not necessarily. The two sources have different economics.

ParameterDistributorManufacturer
Purchase priceUsually higherMay be lower
Replenishment timeUsually shorterOften longer
Minimum order quantityLowerUsually higher
Order flexibilityHigherLower
Required inventoryUsually lowerOften higher
Capital requirementUsually lowerOften higher
Excess inventory riskLowerHigher

Price shows the cost of one unit of product. Inventory shows what the chain has to carry to obtain that price.

A manufacturer’s low purchase price often looks like obvious savings only because part of the cost is not yet visible in the price line. The distributor already holds inventory, splits orders, finances part of the cycle, and allows the chain to buy more frequently and in smaller volumes.

With a direct contract, these functions do not disappear—they move inside the company. That is why two sources of supply should be compared not by the price per unit, but by the cost of the entire system that makes it possible to buy, store, and sell that unit on time.

Book page 58

MARGIN ON INVENTORY INVESTMENT

What margin is actually good?

A high margin percentage by itself says nothing about the quality of a decision. One product may deliver a moderate margin and turn quickly. Another may deliver twice the percentage but require a large lot and sit for months.

You need to look not only at the margin on one sale, but also at how much capital is continuously tied up in inventory to generate that margin.

MARGIN ONLY MAKES SENSE ALONGSIDE THE CAPITAL IT REQUIRES

GROSS MARGIN over 12 months ÷ AVERAGE INVENTORY at purchase cost = GMROI

GMROI shows how much gross margin, in monetary terms, each €1 of average inventory generates over 12 months. In this book: gross margin over 12 months / average inventory at purchase cost.

A PRACTICAL BENCHMARK FOR A PHARMACY CHAIN

<100% — weak return

100-200% — moderate level

200-300% — high performance

>300% — strong economics

These ranges are the author's practical benchmarks for annual GMROI in the pharmacy business, not universal market standards.

A high GMROI should not be considered a good result if it is achieved through chronic shortages. Evaluate it together with the Availability Level.

WHEN THE FUNCTION MOVES INSIDE THE CHAIN

What does the chain actually take over from the distributor?

Direct purchasing changes more than price. The chain begins to aggregate demand itself, place a large order, receive the product at its own warehouse, finance a longer cycle, break down and distribute the product to pharmacies, and maintain the required Availability Level.

WHAT MOVES INSIDE THE CHAIN WITH THE FUNCTION

The chain does not simply capture the distributor's margin; it takes over the functions, costs, and risks behind it.

PREVIOUSLY, PART OF THE FUNCTION WAS PERFORMED BY THE DISTRIBUTOR

  • Holds buffer inventory
  • Receives large lots and breaks them down
  • Consolidates manufacturers' assortments
  • Organizes deliveries to individual pharmacies
  • Partially absorbs demand fluctuations

NOW THE CHAIN TAKES ON

  • Holds and finances its own inventory
  • Receives a large lot and distributes it to pharmacies
  • Manages its purchasing assortment independently
  • Manages its own replenishment cycle
  • Takes on the risk of excess inventory, shortages, and availability

FUNCTION ECONOMICS + RISK + RESPONSIBILITY

The chain should assess the migration of a function based on its full economics and strategic value: margin, capital, service, risk, access, and control. Sometimes a function is justified not because it is cheaper to perform today than an external provider, but because it increases resilience or reduces dependency.

We have taken over the function, and now we must prove that its total economic and strategic value exceeds its cost, complexity, and risk.

PARALLEL TRADE

What should you do if getting a good price requires buying more than your own chain needs?

A manufacturer may offer a lower price at a higher volume. The chain has several options.

HIGHER VOLUME, LOWER PRICE. WHAT SHOULD WE DO WITH THE EXCESS?

1 · DECLINE

if the full economics do not work

2 · BUY AND HOLD

more inventory, capital, and risk

3 · BUY AND RESELL PART

only if it is legal, licensed, and there are buyers

MARKET PERMITS

LICENSES

BUYERS

TRACEABILITY

CAPITAL / RISK

In some European markets, cross-border circulation of original medicinal products, when conducted in accordance with established rules, may constitute parallel trade. For medicines, requirements governing distribution, traceability, packaging, and labeling are particularly important.

A large purchase alone does not turn the chain into a wholesale operator. It requires a lawful resale channel, buyers, and the capability to manage additional inventory, working capital, and risk.

SCALE CAN TURN PURCHASING INTO A WHOLESALE FUNCTION — BUT ONLY IF THERE IS A LAWFUL CHANNEL AND ECONOMIC RATIONALE.

PRIVATE LABEL

Why can private label create more economic value for the chain?

At sufficient scale, a chain can commission production under its own private label. The manufacturer produces the product to an agreed specification.

WHAT THE CHAIN CAN GAIN

  • higher gross margin
  • a differentiated product
  • control over pricing architecture
  • its own brand asset

WHAT SHIFTS TO THE CHAIN

  • choice of manufacturer
  • quality and specification consistency
  • volume forecasting and excess-inventory risk
  • reputational risk attached to its own name

Private label does not create profit automatically.

The chain itself controls the product's place in the assortment, price positioning, volume, its own brand, and the product's route to pharmacies — and it bears the consequences of mistakes itself.

The economic value of private label comes not only from higher margin. The chain gains the ability to manage the offer itself: choose the manufacturer, define the specification, build the pricing architecture, and develop its own brand. But every new element of control simultaneously becomes a new area of responsibility.

Private label therefore works best when the chain can manage not an individual product, but its entire economics — from volume forecasting and the production batch to its place in the category, availability in pharmacies, and customer response. The more functions remain inside the chain, the fewer mistakes can be shifted to an external supplier.

The larger the share of the value-chain economics the chain retains, the more responsibility it must be able to carry.

Book page 62

STEP 5 · DIRECT PURCHASINGILLUSTRATIVE EXAMPLE

FACTORY PHYSICS

How many months of demand are in one batch?

Convert the production batch from units into months of demand.

Chain-wide demand per month

1,000

units

Minimum production batch

24,000

units

24,000 ÷ 1,000 = 24

≈24 months of demand

one minimum production batch equals 24 months of demand

One production batch covers:

1 mo. · 2 mo. · 3 mo. · 4 mo. · 5 mo. · 6 mo. · 7 mo. · 8 mo. · 9 mo. · 10 mo. · 11 mo. · 12 mo. · 13 mo. · 14 mo. · 15 mo. · 16 mo. · 17 mo. · 18 mo. · 19 mo. · 20 mo. · 21 mo. · 22 mo. · 23 mo. · 24 mo.

The longer this horizon, the more capital depends on forecast accuracy.

CAPITAL

how much money is tied up in inventory

SHELF LIFE

will the batch sell in time

DEMAND

what happens if the category changes

Before agreeing on the price, convert the batch into months of demand.

High margin does not compensate for inventory that the chain cannot turn over in time.

FACTORY PHYSICS

Can a high-margin SKU be a poor decision?

Yes. If the minimum production batch contains two years of inventory, a high margin on a single unit may be almost meaningless.

You cannot negotiate against factory physics. But you can decline the purchase if production constraints do not fit the economics of your chain.

THE HIGHEST-MARGIN PRODUCT CAN STILL BE A POOR DECISION IF IT CAUSES THE BUSINESS TO LOSE THE CUSTOMER.

Private label should strengthen the category and customer choice, not force the customer to conform to the chain's internal economics.

THE CATEGORY MANAGER LOOKS AT

  • demand
  • price and margin
  • positioning
  • place in the category

THE FACTORY LOOKS AT

  • minimum economic batch
  • line changeover
  • production frequency
  • production and quality-control lead times

Batch 24,000 units ÷ 1,000 units/month = 24 months of demand

STAGE CHECK · FOR MANAGEMENT

Moving upstream in the chain is economics, not a discount

Direct purchasing and private label become strategic when their total value — margin, capital, service, resilience, access, and control — justifies the risk and complexity of the function.

THE MANAGER SHOULD ASK

  • How do days of inventory change when moving to a direct source?
  • How much capital does the minimum order quantity require?
  • How many months of demand does one mandatory production batch cover?
  • What gross-margin return does average inventory generate for each source?
  • What excess-inventory and expiration risk does the chain take on?
  • Which distributor functions can the chain genuinely perform better itself?
  • Are we increasing private-label margin at the expense of customer choice and trust?

A DIRECT SOURCE SHOULD BE COMPARED NOT BY THE DISCOUNT, BUT BY THE FULL ECONOMICS

DAYS OF INVENTORY

What happens to inventory turnover?

LOT AND CAPITAL

How much money does the mandatory volume require?

MARGIN ON INVENTORY

What return does average inventory generate?

RISK

Excess inventory, expiration risk, complexity of the function.

A direct contract is not a reward for scale; it is a new operational responsibility. If the chain cannot manage inventory, capital, and risk better than under the previous model, the discount merely moves part of the economics and complexity inside the company.

Direct purchasing becomes a strategy when the entire function creates a better overall outcome, both economically and strategically.

HOW MARKET POWER CHANGES

The chain stops being merely a buyer of ready-made distribution.

It can bring the purchasing function in-house, capture part of wholesale economics, develop its own product, and take over part of the manufacturer and distributor functions. A larger discount may already be an expression of negotiating leverage.

Additional lasting power from a new function appears when the chain performs it efficiently enough to justify the added cost and risk.

BUYER OF READY-MADE DISTRIBUTION

BRINGS THE FUNCTION IN-HOUSE

GAINS NEW LEVERAGE

Direct purchasing does not itself create the problem of excess inventory in pharmacies. Excess inventory arises regardless of whether the chain buys from a distributor or directly from a manufacturer. Demand changes. A promotion ends. Sales slow down. The volume purchased may have been too large. Commercial terms may have encouraged the chain to hold additional inventory.

NEW CAPABILITY — SEEING INVENTORY NOT AS HUNDREDS OF SEPARATE BALANCES, BUT AS A SINGLE NETWORK-WIDE RESOURCE.

An in-house warehouse and centralized supply make this function technically possible.

Here, the object of management itself changes. While the chain was focused on purchasing, the main questions were price, terms, and source of supply. But once the product is already inside the system, those decisions are in the past. The outcome now depends on how quickly the chain detects changes in demand and how well it can manage existing inventory as a single resource.

The next stage of the book is therefore not a consequence of direct purchasing, but another function made possible by a mature warehouse system.

TRANSITION · FROM PURCHASING TO MANAGING INVENTORY ALREADY ON HAND

BUYING BETTER IS NOT THE SAME AS MANAGING INVENTORY ALREADY ON HAND.

Direct purchasing does not create excess inventory by itself. Demand keeps changing, and stock at an individual pharmacy can fall out of line with local demand.

The warehouse already knows how to replenish a pharmacy. The next question is what to do with stock already purchased when local demand changes.

PURCHASING

Price, terms, and source are only the beginning.

THE PRODUCT IS ALREADY IN THE SYSTEM

Sales slowed. Demand shifted. Stock is now too high for that location.

NEW CAPABILITY

Treat inventory as one network-wide pool and move it to where it is needed.

THE PRODUCT IS ALREADY IN THE NETWORK. THE QUESTION IS: WHERE IS IT NEEDED?

PHARMACY A — EXCESS STOCK

NETWORK-WIDE INVENTORY POOL

PHARMACY B — NEEDS STOCK

Redistribution (what U.S. retailers often call inventory rebalancing) starts not with another purchase, but with a network-wide view of inventory already on hand: where there is excess and where stock is needed now.

The next stage is redistribution — managing excess stock as one network-wide inventory pool.